Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02651402 · ClinicalTrials.gov registry record · NA
A Hybrid Effectiveness-Implementation Trial of Group CBT in Urban Schools
A NA study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 495
- Enrollment target
NCT02651402: Completed NA study, sponsored by Children's Hospital of Philadelphia.
NCT02651402 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 495 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02651402, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 495 participants
- Enrollment target
Study Summary
Unresolved psychological problems, such as anxiety, affect a significant number of our students and interfere with their ability to attend, actively participate, and prosper in school. This project will expand the capacity of selected mental health agencies to provide services in the participating schools through school therapeutic services (STS). The project will provide enhanced training in evidence-based behavioral health interventions to school-based mental health providers. The services will be implemented by STS Bachelor's or Master's level therapists supervised by their mental health agency supervisors (Internal Support), who are in turn supported by the research team (Train-the-Trainer) or external consultants (Train the Trainer+).
Primary Outcome
Effectiveness between treatment groups will be assessed by comparing the change in diagnostic status from pre to post intervention. Diagnostic status will be assessed using the Anxiety Disorders Interview Schedule for Children (ADIS-P) which includes a semi-structured interview used to determine diagnostic status and outcome. Clinical judgement is used to generate a Clinician Severity Rating (CSR). A CSR \>4 is a clinical diagnosis of an anxiety disorder, CSR=3 patient at risk for developing a d
Interventions
- BEHAVIORAL FRIENDS for Life
- BEHAVIORAL Adapted FRIENDS
- BEHAVIORAL Train-the-Trainer
- BEHAVIORAL Train-the-Trainer Plus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 495 participants |
| Start Date | 2016-02 |
| Est. Completion | 2021-02-28 |
| Phase | NA |
What the finished NCT02651402 record still lists
NCT02651402 is an interventional study that assigns participants to a tested intervention. The registered 495 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 4 interventions - of which FRIENDS for Life is the first listed.
NCT02651402 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02651402 about?
NCT02651402 is a clinical study titled "A Hybrid Effectiveness-Implementation Trial of Group CBT in Urban Schools". Unresolved psychological problems, such as anxiety, affect a significant number of our students and interfere with their ability to attend, actively participate, and prosper in school. This project will expand the capacity of selected mental health agencies to provide services in the participating s...
What is the current status of trial NCT02651402?
This trial is currently completed. It is a NA study. The enrollment target is 495 participants. The study started on 2016-02. Estimated completion is 2021-02-28.
What interventions are being tested in trial NCT02651402?
The interventions under investigation include: FRIENDS for Life (BEHAVIORAL), Adapted FRIENDS (BEHAVIORAL), Train-the-Trainer (BEHAVIORAL), Train-the-Trainer Plus (BEHAVIORAL).
Who is sponsoring clinical trial NCT02651402?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02651402's enrollment target sits among peer trials
495 213th of 2000 higher than 1,788 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03127267 · 495 participants · Phase 3
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- NCT06400472 · 495 participants · Phase 1
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
- NCT05283720 · 496 participants · Phase 2
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
- NCT06417775 · 496 participants · Phase 3
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia